Table I.
Morris water maze assessment of escape latency.
| Group | Saline | NMDA receptor antagonist | 2,6-diisopropylphenol | Total | F-statistic | P-value |
|---|---|---|---|---|---|---|
| Control | 26.65±3.39 | 36.35±3.30 | 34.59±3.91 | 32.53±5.48 | 17.009 | 0.000 |
| ECT | 61.68±8.26 | 45.77±5.53 | 43.93±4.34 | 50.46±10.10 | 19.425 | 0.000 |
| Total | 44.17±19.09 | 41.06±6.56 | 39.26±6.26 | 41.49±12.11 | 3.809a | 0.030a |
| F-statistic | 123.107 | 17.102 | 20.463 | 148.986a | – | – |
| P-value | 0.000 | 0.001 | 0.000 | 0.000a | – | – |
Data are expressed as the mean ± standard deviation (n=8). Crossover effect, F=32.870 and P<0.001;
a
F-statistic and P-value of main effect; ECT, electroconvulsive therapy.